Advisor Group’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Advisor Group’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-23,650	Closed	-$2K	–	4808
2016 Q3	$2K	Hold	23,650	–	–	﹤0.01%	4256
2016 Q2	$8K	Buy	+23,650	New	+$9K	﹤0.01%	3611

Other funds holding PVCT

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

Advisor Group's PVCT Position: Q4 2016 in Review

Advisor Group sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 23,650 shares — an estimated $2K sold.

Advisor Group first reported a position in PVCT in Q2 2016 and held it in 2 quarters. The position peaked at $8K in Q2 2016. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

Advisor Group reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
Advisor Group sold 23,650 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $2K.
Advisor Group first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2016 and held it in 2 quarters.
Advisor Group's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $8K in Q2 2016.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Advisor Group's 13F filing for Q4 2016, filed 31 Jan 2017.